314 related articles for article (PubMed ID: 35639001)
1. Genomic Traits Associated with Virulence and Antimicrobial Resistance of Invasive Group B Streptococcus Isolates with Reduced Penicillin Susceptibility from Elderly Adults.
Koide S; Nagano Y; Takizawa S; Sakaguchi K; Soga E; Hayashi W; Tanabe M; Denda T; Kimura K; Arakawa Y; Nagano N
Microbiol Spectr; 2022 Jun; 10(3):e0056822. PubMed ID: 35639001
[TBL] [Abstract][Full Text] [Related]
2. Clinical and bacterial features of Group B streptococci with reduced penicillin susceptibility from respiratory specimens: a case-control study.
Nishiyama N; Kinjo T; Uechi K; Parrott G; Nakamatsu M; Tateyama M; Fujita J
Eur J Clin Microbiol Infect Dis; 2022 Jan; 41(1):1-8. PubMed ID: 34383176
[TBL] [Abstract][Full Text] [Related]
3. Comparative Analysis of Penicillin-Susceptible and Non-Susceptible Isolates of Group B Streptococci by Multilocus Sequence Typing.
Yamada R; Kimura K; Nagano N; Nagano Y; Suzuki S; Jin W; Wachino J; Yamada K; Shibayama K; Arakawa Y
Jpn J Infect Dis; 2015; 68(4):326-9. PubMed ID: 25720637
[TBL] [Abstract][Full Text] [Related]
4. High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility.
Kimura K; Nagano N; Nagano Y; Suzuki S; Wachino J; Shibayama K; Arakawa Y
J Antimicrob Chemother; 2013 Mar; 68(3):539-42. PubMed ID: 23111853
[TBL] [Abstract][Full Text] [Related]
5. Population-level transition of capsular polysaccharide types among sequence type 1 group B Streptococcus isolates with reduced penicillin susceptibility during a long-term hospital epidemic.
Nagano N; Koide S; Hayashi W; Taniguchi Y; Tanaka H; Maeyama Y; Suzuki M; Kimura K; Arakawa Y; Nagano Y
Int J Antimicrob Agents; 2019 Mar; 53(3):203-210. PubMed ID: 30414439
[TBL] [Abstract][Full Text] [Related]
6. Relatively high rates of cefotaxime- and ceftriaxone-non-susceptible isolates among group B streptococci with reduced penicillin susceptibility (PRGBS) in Japan.
Kitamura M; Kimura K; Ido A; Seki T; Banno H; Jin W; Wachino JI; Yamada K; Arakawa Y
J Antimicrob Chemother; 2019 Apr; 74(4):931-934. PubMed ID: 30649407
[TBL] [Abstract][Full Text] [Related]
7. High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in Japan.
Seki T; Kimura K; Reid ME; Miyazaki A; Banno H; Jin W; Wachino J; Yamada K; Arakawa Y
J Antimicrob Chemother; 2015 Oct; 70(10):2725-8. PubMed ID: 26169560
[TBL] [Abstract][Full Text] [Related]
8. First molecular characterization of group B streptococci with reduced penicillin susceptibility.
Kimura K; Suzuki S; Wachino J; Kurokawa H; Yamane K; Shibata N; Nagano N; Kato H; Shibayama K; Arakawa Y
Antimicrob Agents Chemother; 2008 Aug; 52(8):2890-7. PubMed ID: 18490507
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility profiles, serotype distribution and virulence determinants among invasive, non-invasive and colonizing Streptococcus agalactiae (group B streptococcus) from Malaysian patients.
Eskandarian N; Ismail Z; Neela V; van Belkum A; Desa MN; Amin Nordin S
Eur J Clin Microbiol Infect Dis; 2015 Mar; 34(3):579-84. PubMed ID: 25359580
[TBL] [Abstract][Full Text] [Related]
10. Predominance of sequence type 1 group with serotype VI among group B streptococci with reduced penicillin susceptibility identified in Japan.
Kimura K; Nagano N; Nagano Y; Wachino J; Suzuki S; Shibayama K; Arakawa Y
J Antimicrob Chemother; 2011 Nov; 66(11):2460-4. PubMed ID: 21873288
[TBL] [Abstract][Full Text] [Related]
11. Population Genomics Reveals Distinct Temporal Association with the Emergence of ST1 Serotype V Group B Streptococcus and Macrolide Resistance in North America.
Cubria MB; Vega LA; Shropshire WC; Sanson MA; Shah BJ; Regmi S; Rench M; Baker CJ; Flores AR
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0071421. PubMed ID: 34633844
[TBL] [Abstract][Full Text] [Related]
12. Screening for group B streptococci with reduced penicillin susceptibility in clinical isolates obtained between 1977 and 2005.
Kimura K; Nishiyama Y; Shimizu S; Wachino J; Matsui M; Suzuki S; Yamane K; Shibayama K; Arakawa Y
Jpn J Infect Dis; 2013; 66(3):222-5. PubMed ID: 23698483
[TBL] [Abstract][Full Text] [Related]
13. High isolation rate and multidrug resistance tendency of penicillin-susceptible group B Streptococcus with reduced ceftibuten susceptibility in Japan.
Banno H; Kimura K; Seki T; Jin W; Wachino JI; Yamada K; Nagano N; Arakawa Y
Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1511-1519. PubMed ID: 29770902
[TBL] [Abstract][Full Text] [Related]
14. Active screening of group B streptococci with reduced penicillin susceptibility and altered serotype distribution isolated from pregnant women in Kobe, Japan.
Kimura K; Matsubara K; Yamamoto G; Shibayama K; Arakawa Y
Jpn J Infect Dis; 2013; 66(2):158-60. PubMed ID: 23514916
[TBL] [Abstract][Full Text] [Related]
15. Genomic analysis of virulence factors and antimicrobial resistance of group B Streptococcus isolated from pregnant women in northeastern Mexico.
Palacios-Saucedo GDC; Rivera-Morales LG; Vázquez-Guillén JM; Caballero-Trejo A; Mellado-García MC; Flores-Flores AS; González-Navarro JA; Herrera-Rivera CG; Osuna-Rosales LE; Hernández-González JA; Vázquez-Juárez R; Barrón-Enríquez C; Valladares-Trujillo R; Treviño-Baez JD; Alonso-Téllez CA; Ramírez-Calvillo LD; Cerda-Flores RM; Ortiz-López R; Rivera-Alvarado MÁ; Solórzano-Santos F; Castro-Garza J; Rodríguez-Padilla C
PLoS One; 2022; 17(3):e0264273. PubMed ID: 35294459
[TBL] [Abstract][Full Text] [Related]
16. Potential effect of selective pressure with different β-lactam molecules on the emergence of reduced susceptibility to β-lactams in group B Streptococci.
Koide S; Hayashi W; Taniguchi Y; Tanaka H; Kimura K; Nagano Y; Arakawa Y; Nagano N
Microbiol Immunol; 2019 Feb; 63(2):65-76. PubMed ID: 30632638
[TBL] [Abstract][Full Text] [Related]
17. Genomic and phenotypic characterisation of invasive neonatal and colonising group B Streptococcus isolates from Slovenia, 2001-2018.
Perme T; Golparian D; Bombek Ihan M; Rojnik A; Lučovnik M; Kornhauser Cerar L; Fister P; Lozar Krivec J; Grosek Š; Ihan A; Jeverica S; Unemo M
BMC Infect Dis; 2020 Dec; 20(1):958. PubMed ID: 33327946
[TBL] [Abstract][Full Text] [Related]
18. Genomic insights into the diversity, virulence, and antimicrobial resistance of group B
Alzayer M; Alkhulaifi MM; Alyami A; Aldosary M; Alageel A; Garaween G; Shibl A; Al-Hamad AM; Doumith M
Front Cell Infect Microbiol; 2024; 14():1377993. PubMed ID: 38711928
[TBL] [Abstract][Full Text] [Related]
19. Virulence Profiles and Antimicrobial Resistance of Streptococcus agalactiae Infective and Colonizing Strains from Argentina.
Hernandez LB; Cadona JS; Traverso F; Altamiranda SM; Bustamante AV; Sanso AM
Curr Microbiol; 2022 Nov; 79(12):392. PubMed ID: 36329271
[TBL] [Abstract][Full Text] [Related]
20. Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility.
Dutra VG; Alves VM; Olendzki AN; Dias CA; de Bastos AF; Santos GO; de Amorin EL; Sousa MÂ; Santos R; Ribeiro PC; Fontes CF; Andrey M; Magalhães K; Araujo AA; Paffadore LF; Marconi C; Murta EF; Fernandes PC; Raddi MS; Marinho PS; Bornia RB; Palmeiro JK; Dalla-Costa LM; Pinto TC; Botelho AC; Teixeira LM; Fracalanzza SE
BMC Infect Dis; 2014 Jun; 14():323. PubMed ID: 24919844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
